What’s New in Photon Counting CT?

July 23, 2026 · 10 articles · 10 research themes · covering July 16, 2026 – July 23, 2026

Overview

Across this week’s set of papers, photon-counting CT (PCD/PCCT) emerges as the dominant technical theme, with multiple studies targeting the same core promise: better material discrimination (via spectral/virtual monoenergetic imaging) and higher spatial resolution, translated into improved diagnostic performance and/or reduced radiation dose compared with conventional energy-integrating CT (EID-CT). In coronary imaging, phantom and patient studies focus on low-attenuation plaque and quantitative plaque reproducibility, identifying reconstruction kernels/iterative settings that reduce variability and improve detectability—especially when calcium/iodine content and low-attenuation components challenge conventional CT classification. A preregistered systematic review/meta-analysis further consolidates the clinical rationale for coronary CTA, emphasizing potential reductions in calcium blooming and stenosis overestimation that could lower low-yield downstream invasive angiography.

Outside the heart, the same photon-counting advantages are being stress-tested in broader clinical workflows. Abdominal/pelvic work shows that PCCT can substantially reduce radiation dose while maintaining or improving objective image quality metrics, and qualitative head-to-head comparisons suggest improved visualization of subtle hepato-bilio-pancreatic anatomy. For liver steatosis, a key translational idea is “scan simplification”: using 190-keV virtual monoenergetic images as a surrogate for true non-contrast liver CT to quantify hepatic fat without an additional non-contrast acquisition—if validated. In neurovascular imaging, early feasibility data indicate that photon-counting CT angiography can detect spinal arteriovenous fistulas, leveraging enhanced vascular contrast-to-noise and spatial resolution.

Finally, the digest also highlights how imaging strategy is evolving beyond hardware alone. Whole-body imaging reviews for hematologic malignancies compare CT and MRI in practical decision frameworks, while a narrative review on heart failure emphasizes AI-driven, integrated predictive workflows that move imaging from modality-specific description toward patient-specific phenotyping and risk stratification. Together, these papers suggest a near-term convergence: photon-counting CT improving the physics of tissue characterization, and AI/predictive pipelines improving how that information is interpreted and acted upon in precision care.

---

Photon-Counting CT vs Energy-Integrating CT (Coronary Plaque Quantification)

Coronary plaque quantification on energy-integrating and photon-counting detector CT: reproducibility and power modeling for mixed-platform trials.

This retrospective study compared reproducibility of quantitative coronary plaque characterization between dual-source energy-integrating CT (EID-CT) and photon-counting CT (PCD-CT) in patients undergoing coronary CT angiography within 30 days. Across total and low-attenuation plaque components, the authors identified reconstruction kernel/iterative settings (EID: Qr40 and Bv40; PCD: Bv36/40/44 and Qr36/40/44 with quantum iterative strengths 2–4) that minimized variability and then built a power model to estimate sample sizes for mixed-platform trials. The findings are clinically significant for designing multicenter studies that combine EID-CT and PCD-CT while maintaining quantitative plaque measurement reliability.

Vecsey-Nagy M, Hagar MT, Osoria-Velasquez J et al. · European radiology · (2026) · View on PubMed ↗

---

Photon-Counting CT for Coronary CTA Diagnostic Performance

Comparison of Photon-Counting and Energy-Integrating Computed Coronary Tomography Angiography for Coronary Artery Disease: A Systematic Review and Meta-Analysis.

This preregistered systematic review and meta-analysis compared diagnostic outcomes of photon-counting detector CT (PCD-CT) versus energy-integrating CT (EID-CT) for coronary CT angiography in adults with stable coronary artery disease. The rationale was that PCD-CT’s spectral capability and higher spatial resolution could reduce calcium blooming, improve stenosis quantification, and limit stenosis overestimation, potentially lowering low-yield referrals to invasive coronary angiography. The significance lies in synthesizing comparative evidence to guide whether PCD-CT improves real-world diagnostic accuracy and downstream decision-making in coronary CTA.

Kurugalage R, Bhatia A, Mukherjee A et al. · JACC. Cardiovascular imaging · (2026) · View on PubMed ↗ · Free PDF ↗

---

Photon-Counting CT Spectral/Virtual Monoenergetic Techniques for Coronary Atherosclerosis

Mixed coronary plaque phantom analysis by photon-counting CT: impact of calcium and iodine on low-attenuation plaque detection.

The study evaluated photon-counting detector CT (PCD-CT) versus energy-integrating detector CT (EID-CT) for detecting low-attenuation coronary plaque (LAP) using a mixed-plaque phantom with iodinated lumen, calcified arcs, and a narrow LAP strip. PCD-CT with virtual monoenergetic reconstructions (40–130 keV) and different kernels (soft Qr40 vs sharp Qr72) improved LAP detectability relative to EID-CT, with calcium and iodine content materially affecting LAP visibility. This supports using PCD-CT spectral/iterative reconstruction to better characterize coronary atherosclerosis components that are prone to misclassification on conventional CT.

Szilveszter B, Kolossváry M, Kubovje A et al. · European heart journal. Imaging methods and practice · (2026) · View on PubMed ↗

---

Photon-Counting CT for Abdominal/Body CT Dose and Image Quality

Photon-counting CT vs. energy-integrating detector CT: image quality and radiation dose in multi-phase abdominopelvic imaging.

This prospective study enrolled 94 adults to compare photon-counting CT (PCCT) with energy-integrating CT (EID-CT) in multi-phase abdominopelvic imaging, focusing on radiation dose and objective/subjective image quality. PCCT significantly reduced radiation exposure (CTDIvol, DLP, and normalized DLP) while maintaining or improving objective metrics such as hepatic noise, signal-to-noise ratio (SNR), and contrast-to-noise ratio (CNR), with radiologists scoring image quality on a 5-point Likert scale. The clinical significance is that PCD-CT may deliver dose savings without sacrificing diagnostic image quality in routine abdominal/pelvic CT protocols.

Huang YF, Yang JF, Zhao L et al. · Radiation protection dosimetry · (2026) · View on PubMed ↗

---

Photon-Counting CT for Hepatic Imaging and Steatosis Quantification

Single-Phase Surrogate for True Non-Contrast Liver CT Using 190-keV Monoenergetic Imaging on Photon-Counting CT: Implications for Hepatic Steatosis Assessment.

This retrospective study tested whether 190-keV virtual monoenergetic imaging (VMI) derived from photon-counting detector CT (PCD-CT) can act as a surrogate for true non-contrast (TNC) liver CT in hepatic steatosis quantification. In 49 patients with PCD-CT and MRI-proton density fat fraction (PDFF) within 2 months, attenuation agreement between TNC and 190-keV VMI (and comparison with virtual non-contrast, VNC) was evaluated using correlation and Bland–Altman analyses across four liver segments. If validated, this would enable steatosis assessment without an additional true non-contrast scan, reducing radiation and simplifying workflows.

Ohtani T, Shimada M, Nishiyama K et al. · Academic radiology · (2026) · View on PubMed ↗

---

Photon-Counting CT for Abdominal Organ Visualization (Qualitative/Anatomic Detail)

Photon-counting CT for hepato-bilio-pancreatic imaging: a qualitative head-to-head comparison with third-generation dual-source CT: preliminary results.

In a same-patient retrospective head-to-head comparison, the study assessed qualitative reader-based image quality and anatomical detail of hepato-bilio-pancreatic structures between photon-counting CT (PCCT; Siemens NAEOTOM Alpha pro) and third-generation dual-source energy-integrating CT (EID-CT; Siemens SOMATOM Force). Using comparable contrast-enhanced protocols (with thinner PCCT sections 0.4–0.6 mm vs 1.0 mm for EID-CT), the authors found differences in visualization quality attributable to the photon-counting platform’s spectral/spatial capabilities. This is important for determining whether PCCT can improve diagnostic confidence in abdominal organ assessment where subtle attenuation differences matter.

Foti G, Spoto F, Spezia A et al. · La Radiologia medica · (2026) · View on PubMed ↗

---

Photon-Counting CT Angiography in Neurovascular Disease

Utility of Photon Counting Detector CT Angiography for Detecting Spinal Arteriovenous Fistulas.

This retrospective two-institution case series evaluated the utility of photon-counting detector CT angiography for detecting and characterizing spinal arteriovenous fistulas (AVFs) in eight patients. Leveraging photon-counting CT’s higher spatial resolution and inherent spectral sensitivity to improve vascular contrast-to-noise ratio, the authors demonstrated feasibility for identifying spinal AVFs on CT angiography. Scientifically and clinically, this supports expanding photon-counting CT angiography into neuroradiology for a treatable vascular cause of myelopathy.

Madhavan AA, Bathla G, Hauck EF et al. · AJNR. American journal of neuroradiology · (2026) · View on PubMed ↗ · Free PDF ↗

---

Photon-Counting CT for Hematologic Malignancies and Bone Marrow Disorders

Ultra-High-Resolution Dual-Source Photon-Counting CT for Expanded Characterization of Pathophysiological Imaging Patterns in Multiple Myeloma.

This retrospective study assessed dual-source photon-counting CT (DS-PCCT) for expanded characterization of multiple myeloma skeletal patterns at initial diagnosis using low-keV virtual monoenergetic images (VMI) that exploit attenuation differences between soft tissue and fat. Among 84 patients (53 therapy-naïve MM and 31 precursor conditions), the authors used whole-body DS-PCCT to evaluate axial and appendicular skeletal manifestations with ultra-high spatial resolution and spectral imaging. The significance is that DS-PCCT may improve detection and phenotyping of myeloma-related pathophysiologic imaging patterns, potentially enhancing baseline assessment and monitoring.

Heidemeier A, Huflage H, Rasche L et al. · Investigative radiology · (2026) · View on PubMed ↗ · Free PDF ↗

---

Whole-Body Imaging Modality Selection (CT vs MRI) for Hematologic Disease

Complementary Role of Whole-Body MRI and CT in Hematologic Malignancies and Bone Marrow Disorders.

This clinical review compared whole-body low-dose CT (WBCT) and whole-body MRI (WBMRI) for evaluating hematologic malignancies and bone marrow disorders across diagnosis, staging, response assessment, and surveillance. It concludes that the choice between WBCT and WBMRI depends on practical factors such as scanner access, expertise, patient tolerance, radiation considerations, and cost, with multiple myeloma evidence synthesized from comparative studies. The significance is that it provides a scenario-based decision framework to optimize imaging selection while balancing diagnostic performance and real-world constraints.

Ghotbi E, Frick M, Cook J et al. · Journal of computer assisted tomography · (2026) · View on PubMed ↗

---

Imaging AI and Predictive/Integrated Workflows in Heart Failure

The Future of Imaging in Heart Failure: Toward Precision Phenotyping, Integration, and Intelligence.

This narrative review examined how emerging imaging technologies—especially AI-driven analysis and integrated, predictive workflows—are reshaping heart failure (HF) imaging for precision phenotyping. It highlights a shift from modality-siloed, descriptive imaging toward integrated, patient-specific intelligence that can support etiologic clarification and individualized management. Scientifically, this frames how future HF trials and care pathways may use advanced imaging plus AI to improve risk stratification and treatment targeting.

Hundertmark MJ · Current heart failure reports · (2026) · View on PubMed ↗

---

---

Generated automatically on July 23, 2026. Covers PubMed articles published July 16, 2026 – July 23, 2026. Summaries are AI-generated; always consult the original publication for clinical or research decisions.